Domzaridou, E. ., Carr, M. J., Williams, D. M., Avery, A. J., Van Staa, T. ., Rees, D. A., & Ashcroft, D. M. (2025). Treatment Persistence and Variations in Prescribing Oral, Injectable, and Inhaled Corticosteroids: A Population-Based Drug Utilisation Study. Pharmacoepidemiol Drug Saf, 34, e70153. http://doi.org/10.1002/pds.70153
Administration, Inhalation
Bokern, M. ., Rentsch, C. T., Quint, J. K., Hunnicutt, J. ., Douglas, I. ., & Schultze, A. . (2025). Using Quantitative Bias Analysis to Adjust for Misclassification of COVID-19 Outcomes: An Applied Example of Inhaled Corticosteroids and COVID-19 Outcomes. Pharmacoepidemiol Drug Saf, 34, e70086. http://doi.org/10.1002/pds.70086
Czira, A. ., Banks, V. ., Requena, G. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. . (2024). Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ Open, 14, e072361. http://doi.org/10.1136/bmjopen-2023-072361
Bloom, C. I., Wong, E. ., Hickman, K. ., & Elkin, S. . (2021). Influence of the first wave of COVID-19 on asthma inhaler prescriptions. NPJ Prim Care Respir Med, 31, 45. http://doi.org/10.1038/s41533-021-00260-w
Bloom, C. I., Cullinan, P. ., & Wedzicha, J. A. (2022). Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study. Am J Respir Crit Care Med, 205, 36–45. http://doi.org/10.1164/rccm.202107-1704OC
Requena, G. ., Czira, A. ., Banks, V. ., Wood, R. ., Tritton, T. ., Castillo, C. M., … Ismaila, A. S. (2023). Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 1431–1444. http://doi.org/10.2147/copd.s411437
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231–245. http://doi.org/10.2147/copd.s389281
Halpin, D. M. G., Rothnie, K. J., Banks, V. ., Czira, A. ., Compton, C. ., Wood, R. ., … Vogelmeier, C. F. (2022). Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. Int J Chron Obstruct Pulmon Dis, 17, 2417–2429. http://doi.org/10.2147/copd.s370540
Czira, A. ., Banks, V. ., Requena, G. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England. BMJ Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2022-001243
Rebordosa, C. ., Plana, E. ., Rubino, A. ., Aguado, J. ., Martinez, D. ., Lei, A. ., … Rivero-Ferrer, E. . (2022). Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. Int J Chron Obstruct Pulmon Dis, 17, 1715–1733. http://doi.org/10.2147/copd.s363997